These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 9525644)

  • 1. The proteolytic cleavage of human immunodeficiency virus type 1 Nef does not correlate with its ability to stimulate virion infectivity.
    Chen YL; Trono D; Camaur D
    J Virol; 1998 Apr; 72(4):3178-84. PubMed ID: 9525644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Producer-cell modification of human immunodeficiency virus type 1: Nef is a virion protein.
    Pandori MW; Fitch NJ; Craig HM; Richman DD; Spina CA; Guatelli JC
    J Virol; 1996 Jul; 70(7):4283-90. PubMed ID: 8676450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravirion generation of the C-terminal core domain of HIV-1 Nef by the HIV-1 protease is insufficient to enhance viral infectivity.
    Miller MD; Warmerdam MT; Ferrell SS; Benitez R; Greene WC
    Virology; 1997 Aug; 234(2):215-25. PubMed ID: 9268152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virological importance of the protease-cleavage site in human immunodeficiency virus type 1 Nef is independent of both intravirion processing and CD4 down-regulation.
    Pandori M; Craig H; Moutouh L; Corbeil J; Guatelli J
    Virology; 1998 Nov; 251(2):302-16. PubMed ID: 9837795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virion incorporation of human immunodeficiency virus type 1 Nef is mediated by a bipartite membrane-targeting signal: analysis of its role in enhancement of viral infectivity.
    Welker R; Harris M; Cardel B; Kräusslich HG
    J Virol; 1998 Nov; 72(11):8833-40. PubMed ID: 9765428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human immunodeficiency virus type 1 Nef protein is incorporated into virus particles and specifically cleaved by the viral proteinase.
    Welker R; Kottler H; Kalbitzer HR; Kräusslich HG
    Virology; 1996 May; 219(1):228-36. PubMed ID: 8623533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The membrane-proximal tyrosine-based sorting signal of human immunodeficiency virus type 1 gp41 is required for optimal viral infectivity.
    Day JR; Münk C; Guatelli JC
    J Virol; 2004 Feb; 78(3):1069-79. PubMed ID: 14722262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific cleavage sites of Nef proteins from human immunodeficiency virus types 1 and 2 for the viral proteases.
    Schorr J; Kellner R; Fackler O; Freund J; Konvalinka J; Kienzle N; Kräusslich HG; Mueller-Lantzsch N; Kalbitzer HR
    J Virol; 1996 Dec; 70(12):9051-4. PubMed ID: 8971042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nef enhances human immunodeficiency virus type 1 infectivity resulting from intervirion fusion: evidence supporting a role for Nef at the virion envelope.
    Zhou J; Aiken C
    J Virol; 2001 Jul; 75(13):5851-9. PubMed ID: 11390586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of processed Nef (58-206) with virion proteins of HIV type 1.
    Ciuffi A; Munoz M; Bleiber G; Favre M; Stutz F; Telenti A; Meylan PR
    AIDS Res Hum Retroviruses; 2004 Apr; 20(4):399-407. PubMed ID: 15157358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 Nef enhances both membrane expression and virion incorporation of Env products. A model for the Nef-dependent increase of HIV-1 infectivity.
    Schiavoni I; Trapp S; Santarcangelo AC; Piacentini V; Pugliese K; Baur A; Federico M
    J Biol Chem; 2004 May; 279(22):22996-3006. PubMed ID: 15033985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanistic independence of Nef and cyclophilin A enhancement of human immunodeficiency virus type 1 infectivity.
    Aiken C
    Virology; 1998 Aug; 248(1):139-47. PubMed ID: 9705263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chimeric human immunodeficiency virus type 1 (HIV-1) virions containing HIV-2 or simian immunodeficiency virus Nef are resistant to cyclosporine treatment.
    Khan M; Jin L; Huang MB; Miles L; Bond VC; Powell MD
    J Virol; 2004 Feb; 78(4):1843-50. PubMed ID: 14747548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Antagonism of HIV-1 Nef to SERINC5 Particle Infectivity Restriction Involves the Counteraction of Virion-Associated Pools of the Restriction Factor.
    Trautz B; Pierini V; Wombacher R; Stolp B; Chase AJ; Pizzato M; Fackler OT
    J Virol; 2016 Dec; 90(23):10915-10927. PubMed ID: 27681140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human immunodeficiency virus type 1 particles pseudotyped with envelope proteins that fuse at low pH no longer require Nef for optimal infectivity.
    Chazal N; Singer G; Aiken C; Hammarskjöld ML; Rekosh D
    J Virol; 2001 Apr; 75(8):4014-8. PubMed ID: 11264394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nef enhances HIV-1 infectivity via association with the virus assembly complex.
    Qi M; Aiken C
    Virology; 2008 Apr; 373(2):287-97. PubMed ID: 18191978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 Nef inhibits Protease activity and its absence alters protein content of mature viral particles.
    Mendonça LM; Poeys SC; Abreu CM; Tanuri A; Costa LJ
    PLoS One; 2014; 9(4):e95352. PubMed ID: 24748174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific and distinct determinants mediate membrane binding and lipid raft incorporation of HIV-1(SF2) Nef.
    Giese SI; Woerz I; Homann S; Tibroni N; Geyer M; Fackler OT
    Virology; 2006 Nov; 355(2):175-91. PubMed ID: 16916529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Nef-like effect of murine leukemia virus glycosylated gag on HIV-1 infectivity is mediated by its cytoplasmic domain and depends on the AP-2 adaptor complex.
    Usami Y; Popov S; Göttlinger HG
    J Virol; 2014 Mar; 88(6):3443-54. PubMed ID: 24403584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 Nef association with cellular serine kinase correlates with enhanced virion infectivity and efficient proviral DNA synthesis.
    Wiskerchen M; Cheng-Mayer C
    Virology; 1996 Oct; 224(1):292-301. PubMed ID: 8862424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.